Digital disease management firm Livongo also went public, raising $350 million and has a valuation of over $2.5 billion. As with Health Catalyst, the shares rose over 40% on the first day of trading and even more so, the valuation is ridiculous and the firm will never live up to it. Can you say Castlight or Evolent.
Health Catalyst, the vendor of data analytics for health systems raised $182 million in its initial public offering, and promptly saw a 40% rise in the share price. Don't mean to rain on the parade but this is just an absurd valuation and while the VCs undoubtedly will do well, investors buying in the public market are due for a huge disappointment.
Large European conglomerate Philips has expanded its burgeoning health division by acquiring Medumo, which helps hospitals communicate with patients through text and email.
Phreesia ain't free, as the share price of the scheduling and patient intake software company climbed 40% after its initial public offering that raised $167 million for the company.
Vine Health, a UK company which uses artificial intelligence and behavioral science to improve the lives and outcomes of cancer patients, has raised about $1.4 million in new capital.
Convey Health Solutions, a provider of IT services and outsourcing for health plans providing Medicare Advantage and managed Medicaid packages, is being conveyed from one PE firm to another as New Mountain Capital acquires it from TPG.
DEARhealth, a vendor of data-driven, patient-centric pathways for care of patients with chronic illness, makes investors pay dearly to invest $6.8 million in the firm.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.